Ποια είναι η τιμή για Kobayashi Pharmaceutical Co., Ltd. (4967)

Η τιμή για Kobayashi Pharmaceutical Co., Ltd. (4967) είναι $37.06

Ποια είναι η κεφαλαιοποίηση αγοράς για Kobayashi Pharmaceutical Co., Ltd. (4967)

Η κεφαλαιοποίηση αγοράς για Kobayashi Pharmaceutical Co., Ltd. (4967) είναι $2.75B

Kobayashi Pharmaceutical Co., Ltd. (4967) Τιμή και Κεφαλαιοποίηση Αγοράς

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Η τιμή για 4967	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$68,441.59 $2.75B	NVDA	$5.088T	+184,585.65%
$62,270.17 $2.75B	AAPL	$4.629T	+167,932.43%
$55,389.55 $2.75B	GOOG	$4.118T	+149,365.47%
$49,593.39 $2.75B	MSFT	$3.687T	+133,724.88%
$37,660.61 $2.75B	AMZN	$2.800T	+101,524.96%

Η τιμή για 4967

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$68,441.59 $2.75B